Purpose: Magnetic resonance imaging (MRI) of the brain allows for the identification of structural lesions typical of Alzheimer's disease (AD), the main cause of dementia. However, to have a clinical impact, it is imperative that acquisition and reporting of this MRI-based evidence be standardized, ensuring the highest possible reliability and reproducibility. Our objective was to validate a systematic radiological MRI acquisition and review process in the context of AD. Methods: We included 100 individuals with a suspicion of dementia due to AD for whom MRI were acquired using our proposed protocol of clinically achievable acquisitions and used a unified reading grid to gather semi-quantitative evidence guiding diagnostic. MRIs were read by 3 raters with different experience levels. Interrater reliability was measured using Cohen's kappa statistic. Results: Interrater reliability average for lesions occupying space, hemorrhage, or ischemia, was respectively 0.754, 0.715, and 0.501. Average reliability of white matter hyperintensity burden (Fazekas), global cortical atrophy, and temporal lobe atrophy (Scheltens) scales was 0.687, 0.473, and 0.621 (right)/0.599 (left), respectively. The kappas for regional cortical atrophy (frontal, parietal, occipital, temporal, and posterior cingulum) varied from 0.281e0.678. The average MRI reading time varied between 1.43-5.22 minutes. Conclusions: The presence of space occupying lesions, hemorrhagic or ischemic phenomena, and radiological scales have a good interrater reproducibility in MRI. Coupled with standardized acquisitions, such a protocol should be used when evaluating possible dementias, especially those due to probable AD. 
Conclusions :
A l'IRM, la pr esence de l esions c er ebrales expansives, les ev enements h emorragiques ou isch emiques et les echelles radiographiques ont une bonne reproductibilit e inter evaluateurs. Associ ee a des pratiques d'acquisition normalis ees, l'utilisation d'un tel Dementia is typically defined as a clinical syndrome of cognitive decline that is sufficiently severe to interfere with social or occupational functioning [1] . By 2050, 1 new case of Alzheimer's disease (AD) is expected to develop every 33 seconds, resulting in nearly 1 million new cases per year [2] . In 2016, an estimated 700,000 Americans aged 65 years and older died of complications due to AD [2] . It is imperative that the research and clinical communities to develop approaches to diagnose AD and related disorders accurately and early if clinical management is to slow down its progression. This remains important even though there does not yet exist a pharmacologic regimen to halt disease progression, given that non-pharmacologic approaches have shown promise to reduce if not delay the onset of debilitating cognitive decline and loss of autonomy if they can be applied at the earliest possible time [3] . With magnetic resonance imaging (MRI) of the brain, it is now possible to better identify structural lesions typical of this disease [4] , which can contribute to increased diagnostic accuracy and earlier prognostic. However, in order to ensure that there is no loss of accuracy or predictive value, the highest possible reliability and reproducibility of measurement must be obtained across time and environments. It is therefore crucial that the acquisition and reporting of MRI-based evidence be standardized.
Pathologic and Imaging Findings in AD
The major pathologic findings in AD are (1) the accumulation of amyloid plaques formed by peptide Ab extracellular deposit and (2) an increased production of the tau protein that leads to degeneration caused by neurofibrillary tangles [1] . These pathologic hallmarks debut in the medial temporal lobe, which is the innermost part of the temporal lobe that includes the limbic and paralimbic regions such as the hippocampus and adjacent cortices. Atrophy of this region is typical of AD, following neuronal loss due to its tauopathic component, and is one of its most studied structural parameters [5, 6] . The Scheltens scale [5e7] allows for grading this medial temporal lobe atrophy by evaluating cerebral atrophy at the choroid fissure level, the temporal horn, and the hippocampus [8] , and has been shown to have 95% sensitivity for the clinical diagnosis of AD [9] .
As the disease progresses, there is a reduction in the number of cortical neurons and subsequent loss of grey matter across the entire cortex. The global cortical atrophy (GCA) scale allows for grading sulci diameters, gyri volumes and ventricular system size [10, 11] and hence provides the ability to capture this loss.
Finally, white matter hyperintensities (WMH) are central nervous system damages at the level of the brain white matter caused by vascular impairment, or microangiosclerosis. WMH is found in 30%e40% of all dementia patients. WMH have emerged as robust radiological correlates of cognitive decline [12e15] . WMH distributed in anterior brain regions are related to decline in executive abilities that is typical of normal aging, whereas WMH distributed in more posterior brain regions are common in AD [12, 16] . The Fazekas scale allows for the grading of these white matter changes from the periventricular white matter and basal ganglia damage [17e19].
Objectives
We aimed to report our validation of a systematic radiological review process for standardized acquisitions in the context of AD, with possible applicability to neurodegeneration and other dementias. Our contributions are as follows:
1. A standardized acquisition and review protocol, dubbed the ''Dementia Protocol'' [20] , which is composed of clinically achievable MRI acquisitions, as well as a unified reading grid for evaluation of specific neurodegenerative features related to AD progression (section 2). The protocol allows the assessment of cortical and hippocampal atrophy using T1-weighted MRI and white matter change using fluid-attenuated inversion recovery (FLAIR) and T2* images; and 2. An assessment of the interrater reliability of the Dementia Protocol to evaluate images of individuals seen in neuroradiology for a suspicion of dementia due to probable AD (section 3).
Methods

Ethics
This research project was approved by the ethics committee of the Centre hospitalier universitaire de Quebec (Approbation MP-20-2017-2945).
Participants
We included in this study 100 retrospective individuals for whom MRIs were performed between January 1, 2014, relating to and July 1, 2016, for a suspicion of dementia due to probable AD at the Memory Clinic of Enfant-Jesus Hospital in Quebec City, QC, Canada.
Imaging Protocol
The Dementia Protocol consisted of an axial T1-weighted 3-D scan, axial and coronal FLAIR images, axial T2-weighted scan, axial susceptibility-weighted imaging, axial diffusion (DWI), and an apparent diffusion coefficient map derived from the diffusion scan.
All scans were performed on the same 3 Tesla device (Magnetom; Siemens Healthcare, Erlangen, Germany) at Centre hospitalier universitaire de Quebec (Table 1) .
Reading
The review protocol included the following measurements ( Figure 1 -The qualitative assessment of global cortical atrophy using a modified GCA scale on axial T1-weighted 3-D scan. In this modified scale, lobar (frontal, parietal, occipital, and temporal), and posterior cingulum atrophy were evaluated individually (left, right, hemispheres) using a rating scale from 0 (none)-3 (severe).
Reliability Assessment
All MRIs were read by 3 different raters with different experience levels (2 third-year resident radiologists and 1 board-certified, experienced neuroradiologist). Novice readers (A.A.; L.-O.B.) were trained by the experienced neuroradiologist (M.B.) on the different types of dementia and the scales used to evaluate them [12] . Subsequently, a practice run with MRI using 5 different dementia cases was performed by the 3 raters to ensure the 2 novice readers' understanding of the scales. Following training, each rater evaluated the presence and severity of MRI signs of neurodegeneration using the review protocol in all 5 cases. Reading times were also measured in seconds.
Interrater reliability was measured with Cohen's kappa statistic for binary and ordinal (weighted) outcomes. Confidence intervals (95%) were computed by bootstrapping (n ¼ 1000). Statistics were conducted using the Python module Scikit-learn [21] .
Results
Demographics
The mean age of the participants was 65 years (standard deviation [SD]: 9.61; range 33-82), with 49% being female.
Feasability
The mean scan time for all participants was 25.5 minutes on the 3T platform, which is clinically achievable. The mean reading time was 5 
Interrater Reliability Assessment
Kappas were calculated for each radiological criterion between the 3 raters ( Table 2 ). The kappas for the identification of a lesion occupying space (Figure 2 ) are 0.656, 0.852, and 0.556 for novice 1-experienced, novice 2-experienced, and between the 2 novice raters, respectively. The kappa coefficients for the detection of hemorrhagic phenomenon (Figure 2 
Discussion
The purpose of this research was to report a systematic radiological review process for standardized MRI acquisitions in the context of probable AD, with wider possible applicability to neurodegeneration and dementias. We aimed further to validate its interrater reliability. The study showed that interrater measurements for SOL (0.852) detection, hemorrhagic (0.737), or ischemic (0.556) phenomenon were This lack of reproducibility is probably due to the fact that dementia affects very precise portions of the cerebral lobes.
With only a few gyri to evaluate for each brain lobe, it is sometimes difficult to determine whether atrophy is mild (grade 1) or moderate (grade 2).
We observed the tendency that novice radiologist 2 had a low concordance with novice radiologist 1 (kappas varying from 0.2e0.6) and most of the time, there was a lower concordance with the experienced radiologist than novice radiologist 1. This tendency could be due to his faster reading (1 m, 43 s) than both his colleague (5 m, 22 s) or experienced supervisor (4 m, 13 s). A more complete training prior reading could improve these concordance levels, and would be a possible solution for radiologist who are not familiar with the thorough evaluation of MRIs in dementia.
Conclusions
In conclusion, the presence of SOL, hemorrhagic or ischemic phenomenon, and the use of GCA, Scheltens and Fazekas scales have a good interrater reproducibility even for novice radiology residents in magnetic resonance. Due to their usability, these criteria should be applied by all radiologist when faced with probable AD in order to provide useful and more accurate information for clinicians in their diagnosis workup.
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